AUTL AUTOLUS THERAPEUTICS PLC Accounting Changes 8-K Filing 2024 - Accounting Error Autolus Therapeutics plc has identified an error in the accounting of its research and development tax credits, which should have been recorded as a reduction of research and development expenses instead of income tax expense, impacting its audited consolidated financial statements for the years 2022 and 2021.Get access to all SEC 8-K filings of the AUTOLUS THERAPEUTICS PLC